LG unveils new full-HD smartphone
LG unveils new full-HD smartphone
The Optimus G Pro — the newest version of the Optimus G series and the first LG smartphone offering a full high-definition (HD) screen — will hit stores at home Wednesday, the South Korean firm said.
The new handset is powered by Android software and measures 15.2 centimeters (5.98 inches) long and 7.6 centimeters wide. It goes on sale in Japan and North America in the second quarter.
The Optimus G Pro features a 5.5-inch display that packs over 2 million pixels, or twice as many as smartphones with ordinary HD screens, offering brighter and clearer images.
Global handset makers like Taiwan’s HTC and Sony of Japan have recently rolled out models boasting full HD screens — most commonly used for TVs — to gain an edge in the increasingly competitive smartphone market.
Samsung Electronics, the world’s top maker of both smartphones and mobile handsets in general, is also expected to unveil a new full-HD version of its headline Galaxy S model.
“With smartphones getting bigger and bigger, its visual function becomes ever more important,” LG said in a statement. “An ability to offer high-resolution images is paramount.”
LG, the world’s number two flat-screen TV producer and the fifth biggest phone maker, has struggled for years in the rapidly-growing smartphone market, with its Optimus series lagging far behind Apple’s iPhone or the Galaxy S.
But heavy promotion of new models saw LG’s smartphone sales in the fourth quarter of 2012 surge 56 percent from a year ago to a record 8.6 million units.
Japan to trial ‘world’s first urine test’ to spot cancer
- Previous research has shown a new blood test has potential to detect eight different kinds of tumors before they spread
- The research starts in April and will run until September
TOKYO: A Japanese firm is poised to carry out what it hailed as the world’s first experiment to test for cancer using urine samples, which would greatly facilitate screening for the deadly disease.
Engineering and IT conglomerate Hitachi developed the basic technology to detect breast or colon cancer from urine samples two years ago.
It will now begin testing the method using some 250 urine samples, to see if samples at room temperature are suitable for analysis, Hitachi spokesman Chiharu Odaira told AFP.
“If this method is put to practical use, it will be a lot easier for people to get a cancer test, as there will be no need to go to a medical organization for a blood test,” he said.
It is also intended to be used to detect paediatric cancers.
“That will be especially beneficial in testing for small children” who are often afraid of needles, added Odaira.
Research published earlier this year demonstrated that a new blood test has shown promise toward detecting eight different kinds of tumors before they spread elsewhere in the body.
Usual diagnostic methods for breast cancer consist of a mammogram followed by a biopsy if a risk is detected.
For colon cancer, screening is generally conducted via a stool test and a colonoscopy for patients at high risk.
The Hitachi technology centers around detecting waste materials inside urine samples that act as a “biomarker” — a naturally occurring substance by which a particular disease can be identified, the company said in a statement.
The procedure aims to improve the early detection of cancer, saving lives and reducing the medical and social cost to the country, Odaira explained.
The experiment will start this month until through September in cooperation with Nagoya University in central Japan.
“We aim to put the technology in use in the 2020s, although this depends on various things such as getting approval from the authorities,” Odaira said.